Longeveron appointed Marie Washburn as Senior Vice President and Chief Financial Officer effective July 13, 2026, and added Dr. Arjun “JJ” Desai to its Board as a Class III director effective July 2, 2026.
| IndividualMarie WashburnDr. Arjun “JJ” Desai | RoleSenior Vice President and Chief Financial Officer; principal financial officer and principal accounting officerClass III Director | Type of ChangeAppointedAppointed | Effective DateJuly 13, 2026July 2, 2026 | ReasonReplacement following CFO Lisa Locklear's decision to step down (effective July 10, 2026)To fill a current vacancy on the Board | Replacement InfoReplacing Lisa Locklear (stepping down as CFO effective July 10, 2026)Not disclosed | Background DetailsAge 51; VP & Corporate Controller since Nov 2025; 20+ years in pharma/biotech finance roles including Fore Biotherapeutics, Axcella Health, Generation Bio, Momenta Pharmaceuticals; B.S. Business Administration, Bryant University (1997)Age 45; background details not disclosed in filing | Board/Committee Role ChangesNot disclosedWill receive standard board compensation pro-rated; indemnification agreement to be entered |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.